by Halia Therapeutics | Aug 23, 2023 | News & Media
Thanks to Salt Lake City’s FOX 13 News for attending and reporting on Halia Therapeutics’ grand opening. This report aired August 23,... 
by Halia Therapeutics | Aug 22, 2023 | News & Media
Halia targeting chronic inflammation to keep people healthier, living longer Closely-held Halia Therapeutics is developing a broad pipeline of novel therapies that are essential mediators of immune cell signaling with the potential to improve the lives of... by Halia Therapeutics | Aug 8, 2023 | News & Media
Read the entire article at: www.bioworld.com/articles/699721-in-the-clinic-for-aug-8-2023 by Halia Therapeutics | Jun 19, 2023 | News & Media
https://podcasts.apple.com/us/podcast/episode-37-david-bearss-ph-d-president-and-ceo-of/id1648796570?i=1000616814121 David Bearss, President and CEO of Halia Therapeutics, and Todd Kays, Vice President of Dermatology at Vile Health Technologies, discuss the connection... by Halia Therapeutics | Jun 8, 2023 | News & Media
Halia Therapeutics – Eliminating Chronic Inflammation by Targeting the NLRP3 Inflammasome Dr. David Bearss, PhD, President and CEO at Halia Therapeutics, a clinical-stage biopharma company developing novel therapies to improve the lives of patients with inflammatory... by Halia Therapeutics | Mar 31, 2023 | News & Media
We are proud to announce that Halia CEO David Bearss Ph.D. will be awarded the 2023 Governor’s Medal for Science and Technology on May 2nd at the One Utah Summit. Recipients of the 2023 Utah Governor’s Science Medals... by Halia Therapeutics | Mar 22, 2023 | News & Media
The Bio Report David Bearss Ph.D., president and CEO of Halia Therapeutics, Inc., discusses with Daniel Levine the NLRP3 inflammasome, the role it plays in Alzheimer’s disease and other neurologic conditions, and the case for the company’s therapeutic approach.... by Halia Therapeutics | Mar 22, 2023 | News & Media
Empowered Patient Podcast David Bearss the Co-Founder, CEO and President of Halia Therapeutics, points out that despite traditional thinking, chronic inflammation is not just an unresolved acute inflammatory response. It has been discovered that a different pathway... by Halia Therapeutics | Feb 15, 2023 | News & Media
BioSpace Biopharma Execs Adopt Creative Mindset at BIO CEO https://www.biospace.com/article/biopharma-execs-adopt-creative-mindset-at-bio-ceo-/ by Halia Therapeutics | Jan 20, 2023 | News & Media
STAT Up and down the ladder: The latest comings and goings Up and down the ladder: The latest comings and... by Halia Therapeutics | Jan 20, 2023 | News & Media
Fierce Biotech Chutes & Ladders—David Kessler resigns from the Biden admin, marking the unofficial end of Operation Warp Speed... by Halia Therapeutics | Jan 20, 2023 | News & Media
Endpoints News ‘Perfect time’: SIGA’s CEO on retirement; Juvenescence woos GSK vet to lead anti-aging play ‘Perfect time’: SIGA’s CEO on retirement; Juvenescence woos GSK vet to lead anti-aging... by Halia Therapeutics | Jan 20, 2023 | News & Media
The Pharma Letter Amgen’s Margit Janát-Amsbury named Halia CMO https://www.thepharmaletter.com/article/amgen-s-margit-janat-amsbury-named-halia-cmo by Halia Therapeutics | Jan 19, 2023 | News & Media
BioWorld Appointments and advancements for Jan. 19, 2023 https://www.bioworld.com/articles/693419-appointments-and-advancements-for-jan-19-2023?v=preview by Halia Therapeutics | Jan 17, 2023 | News & Media
CFO DIVE Biotech CFOs sharpen financing tactics for lean times https://www.cfodive.com/news/3-biotech-cfos-finding-financing-lean-times/640301/ by Halia Therapeutics | Nov 16, 2022 | News & Media
David J. Bearss, Ph.D., Co-Founder, and CEO of Salt Lake City-based Halia Therapeutics, for his limitless and inspiring entrepreneurial spirit, mentorship, and achievements that are transforming therapeutics, spawning discovery, seeding startups, and strengthening... by Micah Harman | May 20, 2022 | News & Media
by Jeremie Oliver May 20, 2022 For Utah Business, I’ve covered biotechnology breakthroughs ranging from breast cancer diagnosis to novel intestinal disease therapeutics. But we haven’t yet discussed a disease that is even more prevalent than those combined:... by Micah Harman | Dec 2, 2017 | News & Media
Published: Dec 2, 2017, at 5:20 p.m. By Deseret News PROVO — A new way to examine Alzheimer’s disease has provided a tantalizing potential treatment approach to prevent the devastating condition, according to BYU-led research published online in the...